4//SEC Filing
WHITFIELD ROY A 4
Accession 0001209191-22-050816
CIK 0000906709other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 8:49 PM ET
Size
8.9 KB
Accession
0001209191-22-050816
Insider Transaction Report
Form 4
WHITFIELD ROY A
Director
Transactions
- Award
Common Stock
2022-09-16+10,200→ 246,250 total - Award
Stock Option
2022-09-16+20,400→ 20,400 totalExercise: $3.47Exp: 2030-09-15→ Common Stock (20,400 underlying)
Holdings
- 51,500(indirect: By Trust)
Common Stock
- 20,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.
- [F2]This RSU award vests in full, one year following September 16, 2022.
- [F3]This stock option vests in equal monthly installments over the one-year period beginning on September 16, 2022.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0000936728
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 8:49 PM ET
- Size
- 8.9 KB